Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
Imaging modality and frequency in surveillance of stage I seminoma testicular cancer: Results from a randomized, phase III, factorial trial (TRISST).
Joffe JK. et al, (2021), JOURNAL OF CLINICAL ONCOLOGY, 39
Real-world outcomes in patients receiving neo-adjuvant chemotherapy for early-stage breast cancer
McDonald C. et al, (2021), CANCER RESEARCH, 81
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Turner NC. et al, (2020), Lancet Oncol, 21, 1296 - 1308
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
Hudeček J. et al, (2020), npj Breast Cancer, 6
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Kos Z. et al, (2020), NPJ Breast Cancer, 6
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
Amgad M. et al, (2020), NPJ Breast Cancer, 6
Results from plasmaMATCH: a multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer
Ring A. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 531 - 531
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Kos Z. et al, (2020), NPJ Breast Cancer, 6
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
Amgad M. et al, (2020), NPJ Breast Cancer, 6
Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future
Robinson T. et al, (2020), Clinical Oncology
Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery
Wilson TG. et al, (2020), Clinical Oncology
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Stage 1 Testicular Seminomas Treated with Single Cycle Carboplatin: Outcomes and Management of Relapse: A Single-Centre Experience
Kirk H. et al, (2018), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102, E153 - E153
Stereotactic radiosurgery (SRS) for brain metastases (BM) from breast cancer (BC): A single centre experience of factors influencing survival
Wilson T. et al, (2018), ANNALS OF ONCOLOGY, 29, 117 - 117
Management and outcomes of stage 2a testicular seminoma: a single-centre experience
Kirk H. et al, (2018), CLINICAL ONCOLOGY, 30, E3 - E3
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
Hall DO. et al, (2018), Nucl Med Commun, 39, 161 - 170
Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
Gray R. et al, (2018), CANCER RESEARCH, 78
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39